The effect of using albumin-perfluorohexane/cisplatin-magnetite nanoparticles produced by hydrothermal method against gastric cancer cells through combination therapy

The effect of using albumin-perfluorohexane/cisplatin-magnetite nanoparticles produced by hydrothermal method against gastric cancer cells through combination therapy

Because magnetic nanoparticles (NPs) have the ability to combine different therapies such as drug delivery and photothermal therapy (PTT) along with reducing cancer drug resistance, their use in cancer treatment is considerable. For this purpose, we developed albumin-perfluorohexane/cisplatin-magnet...

Full description

Bibliographic Details
Main Authors:	Dongsheng Li, Yue Fan, Miaomiao Liu, SiLin Huang, Shasha Wang
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Arabian Journal of Chemistry
Subjects:	Gastric cancer Photothermal therapy Chemotherapy Magnetic nanoparticle Cisplatin
Online Access:	http://www.sciencedirect.com/science/article/pii/S1878535223002204

Similar Items

Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer
by: Muharrem Kocar, et al.
Published: (2016-04-01)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
by: Astrid E. Slagter, et al.
Published: (2022-06-01)

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
by: Min‐Hee Ryu, et al.
Published: (2023-04-01)

Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest
by: Mahban Rahimifard, et al.
Published: (2023-01-01)

Cisplatin Induced Nephrotoxicity
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2014-02-01)

Photothermally responsive theranostic nanocomposites for near‐infrared light triggered drug release and enhanced synergism of photothermo‐chemotherapy for gastric cancer
by: Taicheng Zhou, et al.
Published: (2023-01-01)

Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis
by: Chengwei Liu, et al.
Published: (2023-11-01)

Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
by: Noriyuki Hirahara, et al.
Published: (2021-10-01)

Cisplatin-loaded gold nanoshells mediate chemo-photothermal therapy against primary and distal lung cancers growth
by: Shu-Jyuan Yang, et al.
Published: (2023-02-01)

Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study
by: K Govind Babu, et al.
Published: (2019-01-01)

Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways
by: Nang Lae Lae Phoo, et al.
Published: (2022-10-01)

The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
by: Haochen Su, et al.
Published: (2023-10-01)

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
by: Tsutomu Hayashi, et al.
Published: (2020-09-01)

Evaluation of Antagonistic Effects of Metformin with Cisplatin in Gastric Cancer Cells
by: Vahid Lesan, et al.
Published: (2014-09-01)

pH-Sensitive and Long-Circulation Nanoparticles for Near-Infrared Fluorescence Imaging-Monitored and Chemo-Photothermal Synergistic Treatment Against Gastric Cancer
by: Yun Zhou, et al.
Published: (2020-11-01)

The Global mRNA Expression Profiles of Inhibiting PHGDH Induced Cisplatin Resistance in Gastric Cancer
by: Kailing Pan, et al.
Published: (2022-09-01)

A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy
by: Bing Wang, et al.
Published: (2020-12-01)

Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
by: Pramod Kumar Gupta, et al.
Published: (2016-01-01)

Cisplatin-loaded hollow gold nanoparticles for laser-triggered release
by: Chiyi Xiong, et al.
Published: (2018-08-01)

Iron-polydopamine coated multifunctional nanoparticle SiO2@PDA/Fe3+-FA mediated low temperature photothermal for chemodynamic therapy of cisplatin-insensitive osteosarcoma
by: Wenbo Yang, et al.
Published: (2023-03-01)

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
by: Hikmat Abdel-Razeq, et al.
Published: (2018-03-01)

Metformin-induced AMPK activation promotes cisplatin resistance through PINK1/Parkin dependent mitophagy in gastric cancer
by: Yi-Yi Xiao, et al.
Published: (2022-10-01)

XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
by: Natalia Pajuelo-Lozano, et al.
Published: (2018-10-01)

A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer
by: Lili Liu, et al.
Published: (2022-12-01)

Enhanced cisplatin chemotherapy sensitivity by self-assembled nanoparticles with Olaparib
by: Tao Zhang, et al.
Published: (2024-02-01)

Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease
by: Hisato Kawakami, et al.
Published: (2022-11-01)

Histopathological Study of The Effect of Cisplatin on The Ovaries of Females' Albino Mice
by: Intissar N. Waheed, et al.
Published: (2014-12-01)

Chemopreventive Effects of Dietary Isothiocyanates in Animal Models of Gastric Cancer and Synergistic Anticancer Effects With Cisplatin in Human Gastric Cancer Cells
by: Hanne-Line Rabben, et al.
Published: (2021-04-01)

Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance
by: Danyang Li, et al.
Published: (2020-01-01)

Combining Sodium Butyrate With Cisplatin Increases the Apoptosis of Gastric Cancer In Vivo and In Vitro via the Mitochondrial Apoptosis Pathway
by: Yangbo Li, et al.
Published: (2021-08-01)

Role of IL-6/STAT3 Axis in Resistance to Cisplatin in Gastric Cancers
by: Simona Laurino, et al.
Published: (2023-02-01)

Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
by: Makovec Tomaz
Published: (2019-03-01)

circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
by: Shi Wenting, et al.
Published: (2022-02-01)

A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
by: Jitendra Gupta, et al.
Published: (2023-10-01)

APRIL Induces Cisplatin Resistance in Gastric Cancer Cells via Activation of the NF-κB Pathway
by: Xiaofei Zhi, et al.
Published: (2015-01-01)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
by: Yuan Zhang, et al.
Published: (2019-06-01)

Phenethyl Isothiocyanate and Cisplatin Co-Encapsulated in a Liposomal Nanoparticle for Treatment of Non-Small Cell Lung Cancer
by: Mengwei Sun, et al.
Published: (2019-02-01)

Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
by: Mayr Martina, et al.
Published: (2012-12-01)

MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin
by: Yan Qian, et al.
Published: (2020-04-01)

The efficacy of strategies used to minimise or prevent Cisplatin-induced ototoxicity in patients
by: Zenzo S. Chakara, et al.
Published: (2019-01-01)